Risk factors for cognitive impairment in HIV-1-infected persons with different risk behaviors

Archives of Neurology

Volumn 59, Issue 5, 2002, Pages 812-818

  De Ronchi, Diana ^a,b   Faranca, Irma ^a   Berardi, Domenico ^a   Scudellari, Paolo ^a   Borderi, Marco ^a   Manfredi, Roberto ^a   Fratiglioni, Laura ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AGE DISTRIBUTION; APTITUDE TEST; ARTICLE; COGNITION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DRUG USE; EDUCATION; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEROPREVALENCE; SEXUAL BEHAVIOR;

EID: 0036094452     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.59.5.812     Document Type: Article

References (54)

1. Dementia in AIDS patients: Incidence and risk factors
2. Neurocognitive disorders in HIV-1 infection
3. Factors associated with incident human immunodeficiency virus dementia
4. Decreasing incidence of CNS AIDS-defining events associated with antiretroviral therapy
5. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy
6. Variable progression of HIV-associated dementia
7. Estimation of the temporal probability of human immunodeficiency virus (HIV) dementia after risk stratification for HIV-infected persons
8. Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of 132-microglobulin and neopterin
9. Epidemiology of AIDS dementia complex in Europe
10. The Edinburgh cohort of HIV-positive injecting drug users at 10 years after infection: A case-control study of the evolution of dementia
11. Temporal trends in the incidence of HIV-1-related neuroiogic diseases: Multicenter AIDS Cohort Study, 1985-1992
12. Neurological complications of HIV infection
13. Influence of risk group and zidovudine therapy on the development of HIV encephalitis and cognitive impairment in AIDS patients
14. Incidence proportion of and risk factors for AIDS patients diagnosed with HIV dementia, central nervous system toxoplasmosis, and cryptococcal meningitis
15. Comparison of neuropsychological performance between AIDS-free injecting drug users and homosexual men
16. Risk of human immunodeficiency virus type 1-related neurologic disease in a cohort of intravenous drug users
17. The effect of education on dementia occurrence in an Italian population with middle to high socioeconomic status
18. Early neuropsychological impairment in HIV-seropositive intravenous drug users: Evidence from the Italian Multicentre Neuropsychological HIV Study
19. Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection
20. WHO Neuropsychiatric AIDS Study, cross-sectional phase II: Neuropsychological and neurological findings
21. Low education as a possible risk factor for cognitive abnormalities in HIV-1: Findings from the Multicenter AIDS Cohort Study (MACS)
22. Epidemioiogy of human immunodeficiency virus encephalopathy in the United States
23. Mild cognitive impairment and risk of mortality in HIV-1 infection
24. Plasma cobalamin levels affect information processing speed in a longitudinal study of HIV-1 disease
25. 12
26. 12 level as a potential cofactor in studies of human immunodeficiency virus type 1-related cognitive changes
27. Neurologic and neuropsychological manifestations of human immunodeficiency virus infection in intravenous drug users without acquired immunodeficiency syndrome: Relationship to head injury
28. Cognitive deficits and emotional disorders in HIV-1 infected individuals
29. Practice guideline for the treatment of patients with HIV/AIDS
30. Human immunodeficiency virus-associated dementia
31. Development of acute psychotic disorders and HIV-1 infection
32. Neurological outcomes in late HIV infection: Adverse impact of neurological impairment on survival and protective effect of antiviral therapy
33. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
34. Neurocognitive effects of zidovudine and 2′,3′-dideoxyinosine during the treatment of asymptomatic and symptomatic HIV-1 seropositive patients: Comparison with non-treated patients
35. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
36. + cell count
37. Development of a rating scale for primary depressive illness
38. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection: Report of a Working Group of the American Academy of Neurology AIDS Task Force
39. Neuropsychological assessment of substance abusers: Review and recommendations
40. Neuropsychology and the neurochemical lesion: Evolution, applications and extensions
41. Assessment of cognitive functioning in poly-substance abusers
42. Verbal learning and memory in alcohol abusers and polysubstance abusers with concurrent alcohol abuse
43. Neuropsychological functioning in drug abusers
44. Neurologic history and examination results and their relationship to human immunodeficiency virus type 1 serostatus in hemophilic subjects: Results from the hemophilia growth and development study
45. Recombinant activated factor VII (rFVIIa) therapy for intracranial hemorrhage in hemophilia A patients with inhibitors
46. Education and the prevalence of dementia and Alzheimer's disease
47. Education and dementia
48. Cognitive function in asymptomatic HIV infection
49. Declining morbidity and mortality among patients with advanced heuman immunodeffciency virus infection
50. Progressive cerebral volume loss in human immunodeficiency virus infection: A longitudinal volumetric magnetic resonance imaging study
51. AIDS dementia complex in the Italian National AIDS Registry: Temporal trends (1987-93) and differential incidence according to mode of transmission of HIV-1 infection